Any current/future new fundraising through debt or equity?

The company has taken an enabling resolution to raise funds through equity or debt to stay prepared for any growth opportunities. No concrete proposals for inorganic acquisitions or fundraising are currently on the table. The management is evaluating options, particularly for acquisitions in segments like defence, aerospace, and railways. Any future fundraising will be targeted towards long-term business growth. Current gross debt stands at INR576 crores, mainly working capital debt (INR490 crores). The company plans to be free cash flow positive in FY25, with a focus on optimizing working cap

Any current/future capex/capital investment/strategic investment?

Completed organic capex of ~INR333-340 crores in FY24 across multiple projects (Manesar 3, Chennai, Hosur, Pune, Bawal). Average asset utilization as of March 2024 is ~65-70%, indicating capacity to grow without immediate new capex. Planned capex for FY25 is about INR150 crores, mainly for balancing equipment and aimed at FY26 revenue targets. No concrete inorganic acquisition proposals currently, but management is evaluating opportunities in defense, aerospace, and railways to expand product offerings. Enabling resolution passed to raise funds for potential organic or inorganic growth opportu

Future growth expectations in sales/revenue/volumes?

Management targets maintaining a high growth trajectory of 40-45% year-on-year revenue growth in the coming years (Page 23). Exports are expected to continue growing at about 20-30% annually, potentially higher, driven by increased presence in Western Europe and established export base (Pages 22, 23). Healthcare (MedTech) business projected to grow significantly, around 25-30% in the near term, contributing increasingly to revenue and profitability (Pages 12-13). Consumer business expected to stabilize between 37-40% of revenues in FY25, with a management goal to reduce this mix to 30-35% over

Future growth expectations in earnings/operating earnings/profits/EPS?

Management targets a **40-45% CAGR growth** in revenue for FY25, continuing a strong growth trajectory seen over the past 3 years (54% YoY in FY24). **Exports** are expected to grow around **20-30%** in coming years, maintaining their forte with a $100 million export base. Operating EBITDA margin guidance is maintained at **7% for FY25**, slightly improved from 6.8% in FY24, with quarterly variations possible. Profitability expected to stabilize with **stable margins** despite rapid growth, focusing on operational efficiencies and cost control. MedTech vertical is poised to be a signif

Current/ Expected Orderbook/ Pending Orders?

Current order book visibility is approximately INR 4,500 crores. Segment-wise breakup: - Consumer business: ~40% of order book - Industrial business: 20% - 25% - Automotive sector: 20% - 22% - Healthcare: 5% - 7% - Balance from IT and railways Export orders constitute around 22% - 25% of the total order book. Order book remained flat sequentially (around INR 4,500 crores) due to higher execution in Q4, not due to demand slowdown. Railway orders visibility: expected INR 45-50 crores in the current year, with potential to reach INR 25-30 crores revenue in the second h

Syrma SGS Tech.Q4 FY24Industrial Manufacturing

Syrma SGS Tech. Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,718P/E: 90.0Market Cap: ₹33.4K CrSector: Industrial Manufacturing

Management growth scorecard

Revenue

Category 1

Margin

Category 3

Fundraise

Yes

Order

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 1

Management targets maintaining a high growth trajectory of 40-45% year-on-year revenue growth in the coming years (Page 23).
Exports are expected to continue growing at about 20-30% annually, potentially higher, driven by increased presence in Western Europe and established export base (Pages 22, 23).
Healthcare (MedTech) business projected to grow significantly, around 25-30% in the near term, contributing increasingly to revenue and profitability (Pages 12-13).
Consumer business expected to stabilize between 37-40% of revenues in FY25, with a management goal to reduce this mix to 30-35% over the longer term, shifting focus more towards industrial and automotive segments (Pages 19, 12).
Capacity expansion and operational efficiencies are planned to support this growth, with commissioning of new plants and facilities in Pune and Germany slated for FY25 (Pages 4, 22).
ODM design subsidiary expected to start contributing revenues from FY25 onwards, growing steadily thereafter (Page 21).

Margin guidance

Category 3

Management targets a 40-45% CAGR growth in revenue for FY25, continuing a strong growth trajectory seen over the past 3 years (54% YoY in FY24).
Exports are expected to grow around 20-30% in coming years, maintaining their forte with a $100 million export base.
Operating EBITDA margin guidance is maintained at 7% for FY25, slightly improved from 6.8% in FY24, with quarterly variations possible.
Profitability expected to stabilize with stable margins despite rapid growth, focusing on operational efficiencies and cost control.
MedTech vertical is poised to be a significant contributor to bottom line with expected growth of 25-30% and higher in future years.
Company plans positive operating cash flow (OCF) in FY25, with focus on working capital improvement.
No inorganic growth proposals finalized yet, but management is open to strategic acquisitions in defense, aerospace, and railways sectors.

See what Syrma SGS Tech. management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company has taken an enabling resolution to raise funds through equity or debt to stay prepared for any growth opportunities.
No concrete proposals for inorganic acquisitions or fundraising are currently on the table.
The management is evaluating options, particularly for acquisitions in segments like defence, aerospace, and railways.
Any future fundraising will be targeted towards long-term business growth.
Current gross debt stands at INR576 crores, mainly working capital debt (INR490 crores).
The company plans to be free cash flow positive in FY25, with a focus on optimizing working capital to reduce debt reliance.
No immediate plans for debt or equity issuance have been announced; decisions will be communicated once concrete proposals emerge.

Order book

Current order book visibility is approximately INR 4,500 crores.
Segment-wise breakup:
- Consumer business: ~40% of order book
- Industrial business: 20% - 25%
- Automotive sector: 20% - 22%
- Healthcare: 5% - 7%
- Balance from IT and railways
Export orders constitute around 22% - 25% of the total order book.
Order book remained flat sequentially (around INR 4,500 crores) due to higher execution in Q4, not due to demand slowdown.
Railway orders visibility: expected INR 45-50 crores in the current year, with potential to reach INR 25-30 crores revenue in the second half of the year post RDSO approval.
Consumer business is expected to constitute 37%-40% of revenues in FY25, included in order book projections.

See what Syrma SGS Tech. management said on order book — free account, 30 seconds.

Capex plans

Yes

Completed organic capex of ~INR333-340 crores in FY24 across multiple projects (Manesar 3, Chennai, Hosur, Pune, Bawal).
Average asset utilization as of March 2024 is ~65-70%, indicating capacity to grow without immediate new capex.
Planned capex for FY25 is about INR150 crores, mainly for balancing equipment and aimed at FY26 revenue targets.
No concrete inorganic acquisition proposals currently, but management is evaluating opportunities in defense, aerospace, and railways to expand product offerings.
Enabling resolution passed to raise funds for potential organic or inorganic growth opportunities; specific uses to be decided upon firm proposals.
Expansion of 40,000 sq. ft. facility in Stuttgart, Germany planned (fit-out by Q2/Q3 FY25) primarily for integration, with potential future manufacturing.
Commissioning design center in Pune focused on MedTech ODM business expected by Q2 FY25.
Target to optimize working capital and improve operating cash flow alongside these investments.

Track Syrma SGS Tech. — get its next earnings analysis in your feed

How does Syrma SGS Tech. rank vs peers in Industrial Manufacturing?

Pro feature

ThisSyrma SGS Tech.

Rev 1Mar 3

See where Syrma SGS Tech. sits in Industrial ManufacturingSee which companies these are, and every other name in the sector.Open rankings

How does Syrma SGS Tech. rank in Industrial Manufacturing?

Compare Syrma SGS Tech. against every Industrial Manufacturing company (Q4 FY24) on revenue, margins and earnings-call signals.

View Industrial Manufacturing leaderboard →

What Syrma SGS Tech.'s management said in earlier quarters

Others in Industrial Manufacturing this season

Aimtron Electronics Ltd (Q3 FY26)
Current Order Book: ₹98 Crores (Page 8) . Key concall takeaways from Aimtron Electronics Ltd's Q3 FY26 earnings call — and how it ranks against sector peers.
HLE Glascoat Ltd (Q1 FY25)
Q2 FY24 Revenue from Contract with Customers: ₹22,442.1 Lakhs . Key concall takeaways from HLE Glascoat Ltd's Q1 FY25 earnings call — and how it ranks against…
HLE Glascoat Ltd (Q3 FY25)
Q3 FY25 Revenue from Operations: ₹23,102.9 lakhs, down 3.4% YoY (Page 11, 8) . Key concall takeaways from HLE Glascoat Ltd's Q3 FY25 earnings call — and how it…
HLE Glascoat Ltd (Q1 FY24)
Q1 FY24 Revenue from Operations: ₹19,718.7 Lakhs, down 3.5% year-on-year (from ₹20,442.4 Lakhs in Q1 FY23) [Page 7, 8, 10] . Key concall takeaways from HLE…

Compare:vs Mazagon Dock Shipbuilders Ltd vs Indo-MIM Ltd vs Aditya Infotech Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →